These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome]. Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123 [TBL] [Abstract][Full Text] [Related]
27. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822 [TBL] [Abstract][Full Text] [Related]
28. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance. Gaig C; Ezquerra M; Marti MJ; Muñoz E; Valldeoriola F; Tolosa E Arch Neurol; 2006 Mar; 63(3):377-82. PubMed ID: 16533964 [TBL] [Abstract][Full Text] [Related]
29. The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome. Niarchou M; Moore TM; Tang SX; Calkins ME; McDonald-McGuinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE J Psychiatr Res; 2017 Sep; 92():124-131. PubMed ID: 28433949 [TBL] [Abstract][Full Text] [Related]
30. First neuropathological description of a patient with Parkinson's disease and LRRK2 p.N1437H mutation. Puschmann A; Englund E; Ross OA; Vilariño-Güell C; Lincoln SJ; Kachergus JM; Cobb SA; Törnqvist AL; Rehncrona S; Widner H; Wszolek ZK; Farrer MJ; Nilsson C Parkinsonism Relat Disord; 2012 May; 18(4):332-8. PubMed ID: 22154298 [TBL] [Abstract][Full Text] [Related]
31. Reproductive Health Issues for Adults with a Common Genomic Disorder: 22q11.2 Deletion Syndrome. Chan C; Costain G; Ogura L; Silversides CK; Chow EW; Bassett AS J Genet Couns; 2015 Oct; 24(5):810-21. PubMed ID: 25579115 [TBL] [Abstract][Full Text] [Related]
32. [Advance of research on 22q11.2 deletion syndrome]. Zhou H; Weng X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Aug; 41(8):994-1000. PubMed ID: 39097286 [TBL] [Abstract][Full Text] [Related]
33. Histological Analysis of a Mouse Model of the 22q11.2 Microdeletion Syndrome. Tabata H; Mori D; Matsuki T; Yoshizaki K; Asai M; Nakayama A; Ozaki N; Nagata KI Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238632 [TBL] [Abstract][Full Text] [Related]
34. LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons. Henderson MX; Peng C; Trojanowski JQ; Lee VMY Acta Neuropathol Commun; 2018 May; 6(1):45. PubMed ID: 29855356 [TBL] [Abstract][Full Text] [Related]
35. Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2. Martí-Massó JF; Ruiz-Martínez J; Bolaño MJ; Ruiz I; Gorostidi A; Moreno F; Ferrer I; López de Munain A Mov Disord; 2009 Oct; 24(13):1998-2001. PubMed ID: 19735093 [TBL] [Abstract][Full Text] [Related]
36. Parkinson's disease with hypocalcaemia: adult presentation of 22q11.2 deletion syndrome. Moreira F; Brás A; Lopes JR; Januário C BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29572372 [TBL] [Abstract][Full Text] [Related]
37. Biochemical and pathological characterization of Lrrk2. Giasson BI; Covy JP; Bonini NM; Hurtig HI; Farrer MJ; Trojanowski JQ; Van Deerlin VM Ann Neurol; 2006 Feb; 59(2):315-22. PubMed ID: 16437584 [TBL] [Abstract][Full Text] [Related]
38. Identification of 22q11.2 Deletion Syndrome via Newborn Screening for Severe Combined Immunodeficiency. Barry JC; Crowley TB; Jyonouchi S; Heimall J; Zackai EH; Sullivan KE; McDonald-McGinn DM J Clin Immunol; 2017 Jul; 37(5):476-485. PubMed ID: 28540525 [TBL] [Abstract][Full Text] [Related]